62 results
424B5
CTIC
CTI BioPharma Corp
25 Apr 08
Prospectus supplement for primary offering
12:00am
for Zevalin compared to rituximab, the recent adoption of positron emission tomography in community oncology practices, which facilitates use
424B5
CTIC
CTI BioPharma Corp
18 Jul 08
Prospectus supplement for primary offering
12:00am
to adoption, including greater economic incentives and practice efficiencies for Zevalin compared to rituximab, the recent adoption of positron emission
10-12G/A
CTIC
CTI BioPharma Corp
28 Jun 96
Registration of securities (amended)
12:00am
to federal, state and local laws, rules, regulations and policies
governing the use, generation, manufacture, storage, air emission, effluent
discharge
424B5
f0mk r87i66pdh
6 Aug 08
Prospectus supplement for primary offering
12:00am
424B5
9g75 n4e0gk098skad
26 Sep 08
Prospectus supplement for primary offering
12:00am
424B5
vhztyo foa3
23 Jul 08
Prospectus supplement for primary offering
12:00am
424B5
2zva9a555zgfi
29 Jul 08
Prospectus supplement for primary offering
12:00am
424B5
vwvf1ng4gvyi uzzuace
4 Dec 08
Prospectus supplement for primary offering
12:00am
424B5
p5pw0zm sf25v
21 Oct 08
Prospectus supplement for primary offering
12:00am
424B5
41j3i5tz7ndm3c zc
15 Sep 08
Prospectus supplement for primary offering
12:00am
424B5
kbr1vc26jo3bi1
19 Aug 08
Prospectus supplement for primary offering
12:00am
424B5
dj8w wru2zy0j1
30 Apr 08
Prospectus supplement for primary offering
12:00am